氏名

佐藤さとう 幸人ゆきひと

学歴

京都大学医学部医学進学課程 昭和56年4月1日から昭和58年3月31日
京都大学医学部医学科 昭和58年年4月 1日から昭和62年3月31日
京都大学大学院医学研究科博士課程 平成 2年4月 1日から平成 6 年3月31日
京都大学大学院研修員 平成 6年4月 1日から平成 7 年3月31日

職歴

京都大学付属病院にて研修 昭和62年6月1日から昭和63年5月31日
浜松労災病院にて研修 昭和63年6月1日から平成 2 年3月31日
兵庫県立尼崎病院循環器内科医長 平成 7年4月1日から平成13年3月31日
京都大学循環器内科 病棟副医長、病棟医長 平成13年4月1日から平成16年3月31日
兵庫県立尼崎病院循環器内科医長 平成16年4月1日から
兵庫県立尼崎病院循環器内科部長 平成19年4月1日から
兵庫県立尼崎病院循環器内科科長 平成26年4月1日から
兵庫県立尼崎総合医療センター循環器内科長 平成27年7月1日から
      〃       研究部部長     〃     
兵庫県立尼崎総合医療センター診療部長 平成29年4月1日から
      〃       循環器内科長     〃     
      〃       研究部部長     〃     

賞罰

2001年3月 日本内科学会第14回内科学会奨励賞
2001年3月 日本循環器学会第1回高安賞
2006年10月15日 第10回日本心不全学会YIA優秀研究賞(受賞者の直接指導医)

資格、専門医

京都大学大学院医学博士
日本内科学会認定内科医
日本内科学会認定内科専門医
日本内科学会認定内科専門医
日本循環器学会認定循環器専門医
臨床修練指導医

学術関連

京都大学臨床教授 平成20年4月より
徳島大学臨床教授 平成29年4月より
日本循環器学会 「急性および慢性心筋炎の診断治療に関するガイドライン」2004年版 協力者
日本循環器学会 「急性心不全治療ガイドライン」2011年版 協力者
日本循環器学会 「脳卒中と循環器病克服5カ年計画 ストップCVD(脳心血管病) 健康長寿を達成するために」執筆協力者  平成28年12月
日本循環器学会 心臓移植適応検討小委員会 委員  平成26年6月より
日本循環器学会 心臓移植適応検討部会/植込型VAD事後検証部会  平成30年8月より
日本心不全学会 評議員  平成17年10月より
日本心不全学会 心不全予防委員  平成24年より
日本心不全学会 出版・編集委員幹事  平成24年4月より平成28年まで
日本心不全学会 「高齢心不全患者の治療に関するステートメント」策定委員
日本心不全学会 「心不全患者における栄養評価・管理に関するステートメント」策定委員
日本心臓病学会 評議員  平成19年9月より平成28年まで
日本心不全学会 学会誌編集顧問  平成20年より
兵庫県看護協会 認定看護師教育課程 慢性心不全看護コース 講師  平成23年より平成28年まで
兵庫県看護協会 認定看護師教育課程 訪問看護コース 講師  平成24年より平成26年まで
International Heart Journal 編集委員  平成25年
メディカルトリビューン 編集アドバイザー  平成20年4月より平成27年まで
日経メディカル 編集アドバイザー  平成20年8月より平成27年まで
サーキュレーション・アップ・トゥ・デート 編集委員  平成24年より平成27年まで
CORE JOURNAL 循環器 編集委員  平成24年より平成27年まで
日本循環器看護学会誌 専任査読委員  平成25年より平成27年まで
Fluid Management Renaissance 編集アドバイザー  平成25年より平成27年まで
ハートナーシング 編集協力委員  平成25年より平成27年まで

専門

バイオマーカー、急性心不全、慢性心不全、チーム医療

英語論文

  1. Sato Y, Nakagawa Y, Miki H, Suzuki H, Takahashi M. Cardiac angiosarcoma with ruptured right atrium diagnosed by echocardiography. Chest 1991;100:274-5.
  2. Sato Y, Matsumori A. Treatment of coxsackievirus B3 myocarditis by immunoactive peptide in an animal model. Clin Immunol Immunopathol 1992;65:65-9.
  3. Kyu B, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation 1992;86:522-30.
  4. Sato Y, Maruyama S, Kawai C, Matsumori A. Effect of immunostimulant therapy on acute viral myocarditis in an animal model. Am Heart J 1992;124:428-34.
  5. Sato Y, Matsumori A, Sasayama S. Autoantibodies against vimentin in a murine model of myocarditis. Autoimmunity 1994;18:145-8.
  6. Hirozane T, Matsumori A, Furukawa Y, Matsui S, Sato Y, Matoba Y, Sasayama S. Beneficial effect of amrinone on murine cardiac allograft survival. Clin Exp Immunol 1995;102:186-91.
  7. Sato Y, Matsumori A, Sasayama S. Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells. J Mol Cell Cardiol 1995;27:2265-73.
  8. Koshiyama H, Sellitti DF, Akamizu T, Doi SQ, Takeuchi Y, Inoue D, Sakaguchi H, Takemura G, Sato Y, Takatsu Y, Nakao K. Cardiomyopathy associated with Graves' disease. Clin Endocrinol (Oxf) 1996;45:111-6.
  9. Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S. Differential modulation of cytokine production by drugs : implications for therapy in heart failure. J Mol Cell Cardiol 1996;28:2491-9.
  10. Sasayama S, Matsumori A, Matoba Y, Matsui S, Yamada T, Shioi T, Sato Y, Doyama K, Kishimoto C. Immunomodulation: a new horizon for medical treatment of heart failure. J Card Fail 1996;2(4 Suppl):S287-94. Review.
  11. Furukawa Y, Matsumori A, Hirozane T, Matsui S, Sato Y, Ono K, Sasayama S. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. Clin Immunol Immunopathol 1996;79:25-35.
  12. Sato Y, Takatsu Y, Ito H, Kataoka K, Takeuchi Y, Matsumori A. Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect. Heart Vessels 1996;11:218-20.
  13. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takatsu Y. Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 1997;78:505-8.
  14. Wang WZ, Matsumori A, Yamada T, Shioi T, Okada I, Matsui S, Sato Y, Suzuki H, Shiota K, Sasayama S. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation 1997;95:245-51.
  15. Sato Y, Yamada T, Taniguchi R, Kataoka K, Sasayama S, Matsumori A, Takatsu Y. Serum concentration of cardiac troponin T in patients with cardiomyopathy: a possible mechanism of acute heart failure. Heart 1998;80:209-10.
  16. Matsumori A, Ono K, Okada M, Miyamoto T, Sato Y, Sasayama S. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin. J Mol Cell Cardiol 1998;30:2145-9.
  17. Wang WZ, Matsumori A, Matoba Y, Matsui S, Sato Y, Hirozane T, Shioi T, Sasayama S. Protective effects of Mu-Fang-Ji-Tang against myocardial injury in a murine model of congestive heart failure induced by viral myocarditis. Life Sci 1998;62:1139-46.
  18. Taniguchi R, Koshiyama H, Yamauchi M, Tanaka S, Inoue D, Sato Y, Sugawa A, Muramatsu Y, Sasano H. A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. Tohoku J Exp Med 1998;186:215-23.
  19. Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, Matsumori A. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999;22:811-3.
  20. Sato Y, Taniguchi R, Yamada T, Nagai K, Makiyama T, Okada H, Matsumori A, Sasayama S, Takatsu Y. Measurement of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: a sensitive non-invasive marker of cardiac disorder. Intern Med 2000;39:350.
  21. Sato Y, Takatsu Y, Yamada T, Kataoka K, Taniguchi R, Mimura R, Sasayama S, Matsumori A. Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentrations of cardiac troponin T. Jpn Circ J 2000;64:321-4.
  22. Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, Kataoka K, Ito H, Matsumori A, Sasayama S, Takatsu Y. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103: 369-374.
  23. Matsumori A, Furukawa Y, Hasegawa K, Sato Y, Nakagawa H, Morikawa Y, Miura K, Ohno Y, Tamakoshi A, Inaba Y, Sasayama S. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys. Circ J 2002;66:323-36.
  24. Sato Y, Taniguchi R, Makiyama T, Nagai K, Okada H, Yamada T, Matsumori A, Takatsu Y. Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation. Heart (Scientific letter) 2002; 88: 647 -648.
  25. Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A, Takatsu Y. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart (Scientific letter) 2003;89:659-60.
  26. Sato Y, Yamada T, Matsumori A. Hepatitis C virus and cardiomyopathy. Cardiomyopathies and heart failure. Biomolecular, infectious and immune mechanisms (Review). P325-339. Edited by Akira Matsumori. Kluwer Academic Publishers. 2003.
  27. Sato Y, Kita T, Takatsu Y, Kimura T. Biochemical markers of myocyte injury in heart failure (Review). Heart 2004;90:1110-1113.
  28. Taniguchi R, Sato Y, Yamada T, Ooba M, Higuchi H, Matsumori A, Kita T, Kimura T. Combined Measurements of Cardiac Troponin T and N-terminal pro-Brain Natriuretic Peptide in patients with chronic heart failure. Circ J 2004;68:1160-1164.
  29. Kato T, Sato Y, Nagao K, Horie T, Kataoka K, Miyamoto T, Takatsu Y. Serum cardiac troponin T in cardiac amyloidosis: Serial observations in five patients. Tohoku J Exp Med 2006;2018:163-167.
  30. Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T. Measurements of baseline and follow up concentrations of cardiac troponin T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels 2006;21:344-349.
  31. Sato Y, Miyamoto T, Taniguchi R, Nishio Y, Kita T, Takatsu Y. Current understanding of biochemical markers in heart failure (Review). Med Sci Monit 2006;12:RA252-264.
  32. Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, Nakagawa Y, Kita T, Kimura T. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 2007;71:623-630.
  33. Nisio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, Morimoto T, Kimura T, Kita T. Cardiac troponin T versus other prognostic biochemical markers in patients with congestive heart failure. Circ J 2007;71:631-635.
  34. Kuwabara Y, Sato Y, Miyamoto T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Circ J 2007;71:1047-1051.
  35. Sato Y, Kuwabara Y, Taniguchi R, et al. Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin (Review). Int J Cardiol 2008;126:171-176.
  36. Sato Y, Miyamoto T, Taniguchi R, Nagao K, Matsuoka T, Fukuhara Y, Isoda K, Yamane K, Nishi K, Saijyo S, Fujiwara H, Takatsu Y. The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST. J Cardiol 2009;53:20-27.
  37. Sato Y, Nishi K, Taniguchi R, Miyamoto T, Fukuhara R, Yamane K, Saijyo S, Tanada Y, Yamamoto E, Goto T, Takahashi N, Fujiwara H, Takatsu Y. In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events. J Cardiol 2009; 54:221-30.
  38. Sato Y, Nishi K, Saijo S, Tanada Y, Goto T, Takahashi N, Yamamoto E, Fukuhara R, Miyamoto T, Taniguchi R, Fujiwara H, Takatsu Y. Serial measurements of high sensitive cardiac troponin I in patients with acutely decompensated heart failure treated with carperitide versus nitrates. J Cardiol 2010;56:66-72.
  39. Toda K, Sato Y, Hara T, Hijiya K, Kaneko R, Okada T, Takatsu Y, Fujiwara H, Iwasaki T. Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure. J Clin Lab Anal 2010;24:12-6.
  40. Yoshitani Y, Sato Y. Prediction of Acute Heart Failure Decompensation (EDITORIAL). Circ J 2011;75:55-56.
  41. Sato Y, Yamamoto E, Sawa T, Toda K, Hara T, Iwasaki T, Fujiwara H, Takatsu Y. High-sensitivity cardiac troponin T in essential hypertension. J Cardiol 2011;58:226-231.
  42. Sato Y, Fujiwara H, Takatsu Y. Biochemical markers in heart failure. J Cardiol 2012;59:1-7.
  43. Nishi K, Sato Y, Miyamoto T, Toma M, Taniguchi R, Fukuhara R, Saijo S, Fujiwara H, Takatsu Y. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure. J Cardiol 2012;59:366-373.
  44. Sato Y, Fujiwara H, Takatsu Y. Cardiac troponin and heart failure in the era of high-sensitivity assays. J Cardiol 2012;60:160-7.
  45. Yamamoto E, Sato Y, Sawa T, Fujiwara T, Fujiwara H, Takatsu Y. Correlation between serum concentrations of B-type natriuretic Peptide and albumin in patients with chronic congestive heart failure. Int Heart J 2012;53:234-237.
  46. Tanada Y, Sato Y, Sawa T, Fujiwara H, Takatsu Y. Serial measurements of high-sensitivity cardiac troponin I and N-terminal B-type natriuretic peptide in a patient presenting with cardiac sarcoidosis. Intern Med 2012;51:3379-81.
  47. Sato Y. Angiotensin II receptor blockers for patients with chronic heart failure: The next step forward. J Cardiol 2013;61:307-8.
  48. Sato Y. Diagnostic and prognostic property of NT-proBNP in patients with renal dysfunction. J Cardiol 2013;61:446-7.
  49. Koyama S, Sato Y, Tanada Y, Fujiwara H, Takatsu Y. Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart Failure. Circ Heart Fail 2013;6:227-232.
  50. JointWorking Groups. Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (2010 Joint Working Groups Report) [Digest Version] Guidelines for Treatment of Acute Heart Failure (JCS 2011). Circ J 2013;77:2157-2201.
  51. Sato Y, Minatoguchi S, Nishigaki K, Hirata KI, Masuyama T, Furukawa Y, Uematsu M, Yoshikawa J, Otsuji S, Iida M, Fujiwara H. for the SHYOGI study investigators. Design of prospective study of acute coronary syndrome hospitalization after smoking ban in public places in Hyogo prefecture: Comparison with Gifu, a prefecture without a public smoking ban. J Cardiol 2014;63:165-8.
  52. Koyama S, Sato Y, Tanada Y, Fujiwara H, Takatsu Y. Prognostic contribution of urine osmolality in patients presenting with acute heart failure. Int J Cardiol 2014;174:158-159
  53. Sawa T, Sato Y, Matsuda M, Tanaka M, Miyazaaki S, Furukawa Y, Kita Y, Takatsu Y, Fujiwara H.Regression of Electrocardiographic Signs of Left Ventricular Hypertrophy by Combined Treatment With Thiazide Diuretic and Angiotensin-Ⅱ Receptor Blocker. –Randomized Multicenter Trial- Circ J 2014;78:2719-2726
  54. Shionimya H, Koyama S, Tanada Y, Takahashi N, Fujiwara H, Takatsu Y, Sato Y.  Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure. J Cardiol. 2015;65:526-30.
  55. Yoshitani K, Miyamoto T, Sato Y, Takatsu Y. Another gate keeper to protect the mitral isthmus? Importance of the vein of Marshall. J Cardiovasc Electrophysiol 2015;26:352-3.
  56. Sato Y. Multidisciplinary management of heart failure just beginning in Japan. J Cardiol. 2015;66:181-8
  57. Sato Y. Renin- A Historical Biomarker of Heart Failure. Circ J 2015;79:1206-12018
  58. Kujira K, Yoshitani K, Futsuki A, Imai K, Hiraumi Y, Sakazaki H, Sato Y, Takatsu Y, Toyohara K, Fujiwara K Ventricular Tachycardia Rotating a Scar of a Total Right Ventricular Exclusion. Ann Thorac Surg 2015;100:1886-8.
  59. Inazumi H, Koyama S, Tanada Y, Fujiwara H, Takatsu Y, Sato Y. Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation. J Cardiol 2016;67:98-103.
  60. Nakayama H, Koyama S, Kuragaichi T, Shiba M, Fujiwara H, Takatsu Y, Sato Y. Prognostic Value of Rising Serum Albumin During Hospitalization in Patients With Acute Heart Failure. Am J Cardiol 2016;117:1305-9.
  61. Sato Y, Minatoguchi S, Nishigaki K, Hirata KI, Masuyama T, Furukawa Y, Uematsu M, Yoshikawa J, Otsuji S, Iida M, Fujiwara H; SHYOGI Study Investigators..  Results of a Prospective Study of Acute Coronary Syndrome Hospitalization After Enactment of a Smoking Ban in Public Places in Hyogo Prefecture - Comparison With Gifu, a Prefecture Without a Public Smoking Ban. Circ J. 2016;80:2528-2532.
  62. Yamamoto E, Kato T, Ozasa N, Yaku H, Inuzuka Y, Tamaki Y, Kitai T, Morimoto T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawashima T, Motohashi Y, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Shioi T, Kimura T; KCHF study investigators. Kyoto Congestive Heart Failure (KCHF) study: rationale and design. ESC Heart Fail 2017;4:216-223.
  63. Koyama S, Kuragaichi T, Sato Y, Kuwabara Y, Usami S, Horie T, Baba O, Hakuno D, Nakashima Y, Nishino T, Nishiga M, Nakao T, Arai H, Kimura T, Ono K. Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation. ESC Heart Fail 2017;4:112-121.
  64. Nagao K, Tamura A, Morimoto T, Shimamura K, Yukawa H, Ito H, Hayashi F, Makita T, Takemura G, Sato Y, Inada T, Kimura T, Tanaka M Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course. Int J Cardiol 2017;236:483-487.
  65. Kurozumi Y, Oishi S, Sugano Y, Sakashita A, Kotooka N, Suzuki M, Higo T, Yumino D, Takada Y, Maeda S, Yamabe S, Washida K, Takahashi T, Ohtani T, Sakata Y, Sato Y. Design of a nationwide survey on palliative care for end-stage heart failure in Japan. J Cardiol 2018;71:202-211.
  66. Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T; KCHF Study Investigators. Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan - Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry. Circ J 2018;82:2811-2819.
  67. Shimizu Y, Yoshitani K, Murotani K, Kujira K, Kurozumi Y, Fukuhara R, Taniguchi R, Toma M, Miyamoto T, Kita Y, Takatsu Y, Sato Y. The deeper the pouch is, the longer the radiofrequency duration and higher the radiofrequency energy needed-Cavotricuspid isthmus ablation using intracardiac echocardiography. J Arrhythm 2018;34:410-417.
  68. Tsuji S, Koyama S, Taniguchi R, Fujiwara T, Fujiwara H, Sato Y. Nutritional status of outpatients with chronic stable heart failure based on serum amino acid concentration. J Cardiol 2018;72:458-465.
  69. Kuragaichi T, Kurozumi Y, Ohishi S, Sugano Y, Sakashita A, Kotooka N, Suzuki M, Higo T, Yumino D, Takada Y, Maeda S, Yamabe S, Washida K, Takahashi T, Ohtani T, Sakata Y, Sato Y. Nationwide Survey of Palliative Care for Patients With Heart Failure in Japan. Circ J 2018;82:1336-1343.
  70. Sato Y, Kita Y, Shimada M, Matsushita K, Fujiwara H. Survey on the Status of Smoking Inside Eating Establishments in the Cities of Kobe and Amagasaki. Circ J 2018;82:1852-1857.
  71. Tsuji S, Koyama S, Taniguchi R, Fujiwara T, Fujiwara H, MD, Sato Y. Association of Serum Amino Acid Concentration WithLoss of Skeletal Muscle Mass After 1 Year in Cardiac Rehabilitation Center Patients. Circ Reports 2019; 1: 456 – 46.
  72. Su K, Kato T, Toyofuku M, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Motohashi Y, Watanabe H, Kitai T, Taniguchi R, Iguchi M, Kato M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Jinnai T, Kawato M, Sato Y, Kuwahara K, Tamura T, Kimura T, KCHF Registry Investigators. Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart Failure. Circ Reports 2019: 1:517-524.
  73. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T. Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry. J Thromb Thrombolysis019 Jul 5. doi: 10.1007/s11239-019-01913-x. [Epub ahead of print]
  74. Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T. Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure. JAMA Netw Open 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.
  75. Kamiya K, Yamamoto T, Tsuchihashi-Makaya M, Ikegame T, Takahashi T, Sato Y, Kotooka N, Saito Y, Tsutsui H, Miyata H, Isobe M. Nationwide Survey of Multidisciplinary Care and Cardiac Rehabilitation for Patients With Heart Failure in Japan - An Analysis of the AMED-CHF Study. Circ J 2019;83:1546-1552.
  76. Kuragaichi T, Kataoka Y, Miyakoshi C, Miyamoto T, Sato Y. External validation of pooled cohort equations using systolic blood pressure intervention trial data. BMC Res Notes 2019;12:271.
  77. Nishimoto Y, Fukuhara R, Toma M, Taniguchi R, Miyamoto T, Sato Y. Vascular responses to a Viabahn stent graft: evaluation with computed tomographic angiography, angiography, and angioscopy. Cardiovasc Interv Ther 2019;34:390-392.
  78. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T. Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onset - From the COMMAND VTE Registry. Circ J 2019;83:1377-1384.
  79. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart Vessels 2019;34:669-677.
  80. Kurozumi Y, Oishi S, Sugano Y, Sakashita A, Kotooka N, Suzuki M, Higo T, Yumino D, Takada Y, Maeda S, Yamabe S, Washida K, Takahashi T, Ohtani T, Sakata Y, Sato Y. Possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure: a nationwide cross-sectional questionnaire survey. Heart Vessels 2019;34:452-461.
  81. Nakayama H, Toma M, Kobayashi T, Ohno N, Okada T, Ueno G, Sato Y. Ruptured Abdominal Aortic Aneurysm Treated by Double-Balloon Technique and Endovascular Strategy: Case Series. Ann Thorac Cardiovasc Surg 2019;25:211-214.
  82. Nishimoto Y, Fukuhara R, Miyamoto T, Toma M, Miyata A, Sato Y. Edge restenosis of a polytetrafluoroethylene-covered stent in the superficial femoral artery: insights from an imaging assessment with an electronic high-resolution angioscope. Cardiovsc Interv Ther 2020;35:98-100.
  83. Ikeda S, Fukuhara R, Nishimoto Y, Taniguchi R, Sato Y. A percutaneous intravascular cracking (PICKING) with a TruePath™ for extremely calcified lesions. Cardiovsc Interv Ther 2020;35:310-12.
  84. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Group. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry. J Thromb Haemost. 2020;18:624-632.
  85. Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Kato M, Ikeda T, Furukawa Y, Nakagawa Y, Sato Y, Kuwahara K, Kimura T. Risk factors and clinical outcomes of functional decline during hospitalization in very old patients with acute decompensated heart failure: an observational study. BMJ Open In Press.
  86. Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Association with Controlling Nutritional Status (CONUT) Score and In-hospital Mortality and Infection in Acute Heart Failure. Sci Rep 2020 Feb 24;10(1):3320. doi: 10.1038/s41598-020-60404-9.
  87. Ikeda S, Imai M, Yoshizawa K, Miyamoto T, Fujiwara K, Sato Y. Cardiac erosion causing an aortic dissection after a catheter closure of an atrial septal defect: first late erosion case with the Figulla Flex II septal occluder. Cardiovasc Interv Ther 2020 Apr 4. doi: 10.1007/s12928-020-00664-4. [Epub ahead of print]
  88. Nagao K, Tamura A, Sato Y, Hata R, Kawase Y, Kadota K, Horie T, Sowa N, Nishiga M, Ono K, Inada T, Tanaka M. Utility of collagen-derived peptides as markers of organ injury in patients with acute heart failure. Open Heart 2020 Apr 5;7(1):e001041. doi: 10.1136/openhrt-2019-001041. eCollection 2020.
  89. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators. Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry. Thromb Res 2020;191:66-75.
  90. Miyagawa S, Miyamoto T, Sato Y. Soluble Tumour Necrosis Factor-Alpha Receptor Improved the Function, Hypertrophy, and Granular Sparkling Appearance of the Left Ventricular Myocardium in Systemic Amyloid A Amyloidosis: A Case Report. Eur Heart J Case Rep. 2020;4:1-7.
  91. Yamamoto K, Tsuchihashi-Makaya M, Kinugasa Y, Iida Y, Kamiya K, Kihara Y, Kono Y, Sato Y, Suzuki N, Takeuchi H, Higo T, Miyazawa Y, Miyajima I, Yamashina A, Yoshita K, Washida K, Kuzuya M, Takahashi T, Nakaya Y, Hasebe N, Tsutsui H; Japanese Heart Failure Society, Expert Consensus Writing Committee. Japanese Heart Failure Society 2018 Scientific Statement on Nutritional Assessment and Management in Heart Failure Patients. Circ J. 2020;84:1408-1444.
  92. Yamamoto E, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Himura Y, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Sex differences in patients with acute decompensated heart failure in Japan: observation from the KCHF registry. ESC Heart Fail. 2020;5:2485-2493.
  93. Nishimoto Y, Toma M, Matsui Y, Fukuhara R, Miyamoto T, Sato Y. Successful Fogarty venous thrombectomy without a skin incision for organized thrombi caused by May-Thurner syndrome. Cardiovasc Interv Ther. In press.
  94. Yoshikawa Y, Tamaki Y, Morimoto T, Yaku H, Yamamoto E, Inuzuka Y, Ozasa N, Kitai T, Nagao K, Sato Y, Kondo H, Tamura T, Nakagawa Y, Kuwahara K, Kato T, Kimura T. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry. PLoS One doi: 10.1371/journal.pone.0239100. eCollection 2020.
  95. Kamiya K, Sato Y, Takahashi T, Tsuchihashi-Makaya M, Kotooka N, Ikegame T, Takura T, Yamamoto T, Nagayama M, Goto Y, Makita S, Isobe M. Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure. Circ Heart Fail: In Press.
  96. Nishimoto Y, Yamashita Y, Kim K, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry. Circ J: In Press.
  97. Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Association between body mass index and prognosis of patients hospitalized with heart failure. Sci Rep. 2020 Oct 7;10(1):16663.
  98. Hata R, Kato T, Yaku H, Morimoto T, Kawase Y, Yamamoto E, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Morinaga T, Furukawa Y, Kadota K, Sato Y, Kimura T. Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry. J Cardiol: In Press.
  99. Natsuaki M, Morimoto T, Shiomi H, Ehara N, Taniguchi R, Tamura T, Tada T, Suwa S, Kaneda K, Watanabe H, Tazaki J, Watanabe S, Yamamoto E, Saito N, Fuki M, Takeda T, Eizawa H, Shinoda E, Mabuchi H, Shirotani M, Uegaito T, Matsuda M, Takahashi M, Inoko M, Tamura T, Ishii K, Onodera T, Sakamoto H, Aoyama T, Sato Y, Ando K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-3. Circ J: In Press.
  100. Kuragaichi T, Sato Y. Temporal trends of a vasopressin V 2 receptor antagonist in heart failure using a nationwide database in Japan. ESC Heart Fail: In Press.
  101. Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Shiba M, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study. PLoS One. 2020 Dec 28;15(12):e0243818.
  102. Nishimoto Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Kuwahara K, Ozasa N, Sato Y, Kimura T. C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study. BMJ OpenBMJ Open. 2020 Dec 29;10(12):e041068.
  103. Yamamoto K, Shiomi H, Morimoto T, Kadota K, Tada T, Takeji Y, Matsumura-Nakano Y, Yoshikawa Y, Imada K, Domei T, Kaneda K, Taniguchi R, Ehara N, Nawada R, Natsuaki M, Yamaji K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 investigators. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3). Am J Cardiol. 2021 Jan 14:S0002-9149(21)00035-7.
  104. Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Kadota K, Imada K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Kato E, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With versus Without Chronic Kidney Disease. Am J Cardiol. 2021 Jan 14:S0002-9149(21)00036-9.
  105. Tsujimoto H, Kataoka Y, Sato Y, Banno M, Tsujino-Tsujimoto E, Sumi Y, Sada R, Fujiwara T, Ohtake Y, Kumasawa J, Imura H, Matsuda Y, So R, Kagawa T, Yoshioka T, Uneno Y, Nagano H, Akazawa M, Hozumi T, Tsujimoto Y. A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivity. BMC Med Educ. 2021 Feb 10;21(1):98. doi: 10.1186/s12909-021-02538-6.
  106. Takeji Y, Shiomi H, Morimoto T, Yoshikawa Y, Taniguchi R, Mutsumura-Nakano Y, Yamamoto K, Yamaji K, Tazaki J, Suwa S, Inoko M, Takeda T, Shirotani M, Ehara N, Ishii K, Inada T, Onodera T, Shinoda E, Yamamoto T, Tamura T, Nakatsuma K, Sakamoto H, Ando K, Soga Y, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Komiya T, Minatoya K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 and the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3. BMJ Open. 2021 Feb 22;11(2):e044329. doi: 10.1136/bmjopen-2020-044329.
  107. Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Prognostic value of reduction in left atrial size during a follow-up of heart failure: an observational study. BMJ Open. 2021 Feb 19;11(2):e044409. doi: 10.1136/bmjopen-2020-044409.
  108. Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Serum cholinesterase as a prognostic biomarker for acute heart failure. Eur Heart J Acute Cardiovasc Care. 2021 Jan 18:zuaa043. doi: 10.1093/ehjacc/zuaa043. Online ahead of print.
  109. Nishimoto Y, Toma M, Miyamoto R, Miyata A, Sato Y. Successful Percutaneous Fogarty Arterial Thrombectomy for Acute Lower Limb Ischemia. JACC Cardiovasc Interv. 2021 Feb 17:S1936-8798(20)32396-7.

以上